Probiotics: From clinical trial to health claims success

By Stephen Daniells

- Last updated on GMT

Related tags: Nutrition, Efsa

As a raft of non-positive opinions on probiotics floats down the health claims river, questions have been asked of the efficacy of the beneficial bacteria. Two experts discuss where we stand and how to get the good ship Probiotic back on course.

Chr Hansen's Svend Laulund and Joerg Gruenwald, president of CRO, Analyze & Realize talk to Stephen Daniells about what the recent EFSA rejections really mean for probiotics.

Laulund and Gruenwald also discuss how to fulfill EFSA's criteria and achieve a positive health claim. A good place to start would be correct characterisation of the strains, quickly followed by conducting studies in healthy populations.

These issues and more will be discussed at the upcoming NutraIngredients Health Claims 2010 conference in Brussels. Danone will discuss its response to the health claims process along with Provexis and others on Thursday, 10th December. Others include Unilever, analyze&realize, Cantox, academics, industry groups, lawyers and market experts. For more information and to register, please click here​.

Related news

Show more

Related products

show more

Fermented Soy for Natural Digestive Support

Fermented Soy for Natural Digestive Support

Lallemand Bio-Ingredients | 22-Apr-2019 | Technical / White Paper

Lallemand is running a new clinical trial for Gastro-AD® in spring 2019. Gastro-AD® is a clinically studied food supplement based on non-GMO soy fermented...



BIONAP Srl | 18-Apr-2019 | Interview

At VITAFOODS 2019, BIONAP will present a wide range of sustainable and innovative solutions for: BRAIN HEALTH , SPORT & NUTRITION, SKIN PROTECTION,...

Related suppliers

Follow us

Featured Events

View more


View more